Matsuda Masaru
SEC CIK 1798679 · EDGAR
BoughtSold
Most active insiders at ARQT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watanabe Todd | See Remarks, Dir | — | $5.32M |
| 2 | Welgus Howard G. | Dir | — | $2.43M |
| 3 | Matsuda Masaru | See Remarks | — | $2.21M |
| 4 | Burnett Patrick | See Remarks | — | $2.02M |
| 5 | Leonard Keith R | Dir | — | $997.1K |
| 6 | Curran Terrie | Dir | — | $984.0K |
| 7 | Edwards Larry Todd | See Remarks | — | $968.4K |
| 8 | Krishnamohan Neha | Dir | — | $939.5K |
| 9 | LIN SUE-JEAN | Dir | — | $898.5K |
| 10 | Gilbert Halley E | Dir | — | $455.5K |
Transactions 41
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-18 16:17 | 2026-09-16 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $25.00 | -3,674 | 112.5K | -3% | -$91.9K |
| T | 2026-09-10 19:24 | 2026-09-08 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $25.03 | -9,989 | 116.2K | -8% | -$250.0K |
| T | 2026-08-05 21:42 | 2026-08-03 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $26.12 | -1,230 | 126.2K | -1.0% | -$32.1K |
| MT | 2026-05-06 19:40 | 2026-05-04 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $23.31 | -8,256 | 126.7K | -6% | -$192.4K |
| DM | 2026-03-03 | 2026-02-27+ | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $26.03 | -12.1K | 136.9K | -8% | -$313.9K |
| D | 2026-03-03 | 2026-02-27 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | A - Grant | $0.00 | +37.0K | 147.0K | +34% | $0 |
| M | 2026-02-04 | 2026-02-02 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $25.28 | -40.6K | 134.1K | -23% | -$1.03M |
| 2025-12-03 | 2025-12-01 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $30.23 | -1,657 | 150.6K | -1% | -$50.1K | |
| M | 2025-11-21 | 2025-11-19 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $28.29 | -2,550 | 151.5K | -2% | -$72.1K |
| M | 2025-11-05 | 2025-11-03 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $24.71 | -7,208 | 154.0K | -4% | -$178.1K |
| 2025-09-08 | 2025-09-04 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $16.16 | -36.1K | 161.2K | -18% | -$583.9K | |
| 2025-08-05 | 2025-08-04 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $14.33 | -6,330 | 197.4K | -3% | -$90.7K | |
| 2025-05-29 | 2025-05-28 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $13.78 | -1,800 | 202.6K | -0.9% | -$24.8K | |
| 2025-05-05 | 2025-05-02 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $15.20 | -5,030 | 204.4K | -2% | -$76.5K | |
| D | 2025-03-04 | 2025-02-28 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | A - Grant | $0.00 | +34.0K | 212.7K | +19% | $0 |
| D | 2025-03-04 | 2025-03-03 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $13.03 | -3,263 | 209.4K | -2% | -$42.5K |
| 2025-02-04 | 2025-02-03 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $12.70 | -8,338 | 178.7K | -4% | -$105.9K | |
| M | 2024-12-03 | 2024-05-31+ | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | P - Purchase | $3.28 | +5,657 | 185.4K | +3% | +$18.5K |
| 2024-11-19 | 2024-11-19 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $9.68 | -1,775 | 181.4K | -1.0% | -$17.2K | |
| 2024-11-19 | 2024-11-18 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | A - Grant | $0.00 | +4,875 | 183.1K | +3% | $0 | |
| 2024-11-05 | 2024-11-04 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $8.68 | -5,015 | 178.3K | -3% | -$43.5K | |
| 2024-08-05 | 2024-08-02 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $9.02 | -5,220 | 183.3K | -3% | -$47.1K | |
| 2024-05-29 | 2024-05-27 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | A - Grant | $0.00 | +4,875 | 190.3K | +3% | $0 | |
| 2024-05-29 | 2024-05-28 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | S - Sale | $9.01 | -1,775 | 188.5K | -0.9% | -$16.0K | |
| 2024-05-03 | 2024-05-02 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | S - Sale | $8.74 | -5,016 | 185.4K | -3% | -$43.8K | |
| 2024-03-06 | 2024-03-04 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | S - Sale | $11.12 | -3,760 | 190.4K | -2% | -$41.8K | |
| DM | 2024-02-15 | 2024-02-13 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | A - Grant | — | +119.5K | 194.2K | +160% | — |
| D | 2024-01-17 | 2024-01-12 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | A - Grant | $0.00 | +28.0K | 74.6K | +60% | $0 |
| 2023-11-21 | 2023-11-18 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | A - Grant | $0.00 | +4,875 | 48.5K | +11% | $0 | |
| 2023-11-21 | 2023-11-21 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | S - Sale | $1.98 | -1,850 | 46.6K | -4% | -$3,663 | |
| M | 2023-06-02 | 2023-05-27+ | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | A - Grant | $1.47 | +6,338 | 43.6K | +17% | +$9,334 |
| 2023-06-02 | 2023-05-31 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | S - Sale | $7.80 | -1,830 | 42.1K | -4% | -$14.3K | |
| D | 2023-03-06 | 2023-03-02 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | A - Grant | $0.00 | +21.0K | 39.1K | +116% | $0 |
| DM | 2023-03-06 | 2023-03-02 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $15.83 | -1,434 | 18.1K | -7% | -$22.7K |
| 2022-11-22 | 2022-11-18 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | A - Grant | $0.00 | +4,875 | 21.3K | +30% | $0 | |
| 2022-11-22 | 2022-11-21 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | S - Sale | $18.19 | -1,720 | 19.5K | -8% | -$31.3K | |
| 2022-06-02 | 2022-05-27 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | SVP, GC | A - Grant | $0.00 | +4,875 | 18.2K | +37% | $0 | |
| 2022-06-02 | 2022-06-02 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | SVP, GC | S - Sale | $19.73 | -1,795 | 16.4K | -10% | -$35.4K | |
| D | 2022-03-07 | 2022-03-03 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | SVP, GC | A - Grant | $0.00 | +13.3K | 13.3K | New | $0 |
| D | 2021-09-07 | 2021-09-04 | HALO | HALOZYME THERAPEUTICS, INC. | Matsuda Masaru | SVP, GC | M - OptEx | $0.00 | +6,883 | 23.5K | +42% | $0 |
| D | 2021-09-07 | 2021-09-04 | HALO | HALOZYME THERAPEUTICS, INC. | Matsuda Masaru | SVP, GC | F - Tax | $42.22 | -3,412 | 20.0K | -15% | -$144.1K |
Purchase Sale Sale after option exercise All abbreviations